Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Carson

Showing results (231-240 of 272) with videos related to

Pageof 28
Sort By:
Cancer Immunology, Immunotherapy : CII|July 9, 2017
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancerRobert Wesolowski, Megan C Duggan, Andrew Stiff, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|August 21, 2013
Pain, depression, and fatigue: loneliness as a longitudinal risk factorLisa M Jaremka, Rebecca R Andridge, Christopher P Fagundes, et al.
Cancer Immunology Research|July 21, 2017
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor FunctionsAmanda R Campbell, Megan C Duggan, Lorena P Suarez-Kelly, et al.
Oncotargets and Therapy|October 13, 2016
MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approachesJoseph Markowitz, Zachary Abrams, Naduparambil K Jacob, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone SarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Blood Advances|February 10, 2019
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinibEmily M McWilliams, Christopher R Lucas, Timothy Chen, et al.
Molecular Therapy. Oncology|November 4, 2024
Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2022
A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine NeoplasmsDwight H Owen, Brooke Benner, Lai Wei, et al.
Plos One|March 16, 2007
Precancerous stem cells have the potential for both benign and malignant differentiationLi Chen, Rulong Shen, Yin Ye, et al.
Therapeutic Advances in Medical Oncology|December 28, 2023
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancerNicole O Williams, Dionisia Quiroga, Courtney Johnson, et al.
Pageof 28

Showing results (231-240 of 272) with videos related to

Sort By:
Pageof 28
Cancer Immunology, Immunotherapy : CII|July 9, 2017
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancerRobert Wesolowski, Megan C Duggan, Andrew Stiff, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|August 21, 2013
Pain, depression, and fatigue: loneliness as a longitudinal risk factorLisa M Jaremka, Rebecca R Andridge, Christopher P Fagundes, et al.
Cancer Immunology Research|July 21, 2017
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor FunctionsAmanda R Campbell, Megan C Duggan, Lorena P Suarez-Kelly, et al.
Oncotargets and Therapy|October 13, 2016
MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approachesJoseph Markowitz, Zachary Abrams, Naduparambil K Jacob, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone SarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Blood Advances|February 10, 2019
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinibEmily M McWilliams, Christopher R Lucas, Timothy Chen, et al.
Molecular Therapy. Oncology|November 4, 2024
Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2022
A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine NeoplasmsDwight H Owen, Brooke Benner, Lai Wei, et al.
Plos One|March 16, 2007
Precancerous stem cells have the potential for both benign and malignant differentiationLi Chen, Rulong Shen, Yin Ye, et al.
Therapeutic Advances in Medical Oncology|December 28, 2023
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancerNicole O Williams, Dionisia Quiroga, Courtney Johnson, et al.
Pageof 28